…33-9) Sodium cyanide; d.46. (C.A.S. #7681-49-4) Sodium fluoride; d.47. (C.A.S. #16893-85-9) Sodium hexafluorosilicate; d.48. (C.A.S. #1313-82-2) Sodium sulfide; d.49. (C.A.S. #637-39-8) Triethanolamine hydrochloride; d.50. (C.A.S. #116-17-6) Tri-isopropyl phosphite. 1C351 Human a…
…develop, we believe the potential benefits of improved care and reduced adverse events that can come from using such functionality and being able to subsequently analyze user actions for DD/DAI interventions outweighs the development burden. To provide health IT developers with f…
… Please responsibly disclose security issues following NVDA's security policy Prevents a situation where NVDA may unexpectedly run as an administrator. GHSA-cq78-fjp7-3rp5 2025.3.2 This is a patch release to fix a security issue. Security fixes Please responsibly disclose securit…
… Please responsibly disclose security issues following NVDA's security policy Prevents a situation where NVDA may unexpectedly run as an administrator. GHSA-cq78-fjp7-3rp5 2025.3.2 This is a patch release to fix a security issue. Security fixes Please responsibly disclose securit…
… Please responsibly disclose security issues following NVDA's security policy Prevents a situation where NVDA may unexpectedly run as an administrator. GHSA-cq78-fjp7-3rp5 2025.3.2 This is a patch release to fix a security issue. Security fixes Please responsibly disclose securit…
… Please responsibly disclose security issues following NVDA's security policy Prevents a situation where NVDA may unexpectedly run as an administrator. GHSA-cq78-fjp7-3rp5 2025.3.2 This is a patch release to fix a security issue. Security fixes Please responsibly disclose securit…